Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus

Acta Diabetologica

Volumn 47, Issue SUPPL. 1, 2010, Pages

  Singh, Dhruv K ^a   Winocour, Peter ^a   Summerhayes, Bev ^a   Viljoen, Adie ^a   Sivakumar, G ^a   Farrington, Ken ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

1,25 dihydroxyvitamin D; Magnesium; Osteoprotegerin; RANKL; Type 1 diabetes

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CALCITRIOL; CALCIUM; COLLAGEN TYPE 1; MAGNESIUM; MINERAL; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE ABSORPTION; MAGNESIUM BLOOD LEVEL; MALE; METABOLITE; MICROALBUMINURIA; MINERAL BLOOD LEVEL; MINERAL METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; VITAMIN BLOOD LEVEL;

ADULT; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALS; OSTEOPROTEGERIN; RANK LIGAND; VITAMIN D;

EID: 78751601127     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0146-z     Document Type: Article

References (24)

1. NX Chen SM Moe 2003 Arterial calcification in diabetes Curr Diab Rep 3 1 28 32 10.1007/s11892-003-0049-2 12643143
2. R Vattikuti DA Towler 2004 Osteogenic regulation of vascular calcification: an early perspective Am J Physiol Endocrinol Metab 286 5 E686 E696 1:CAS:528:DC%2BD2cXkt1emtbo%3D 10.1152/ajpendo.00552.2003 15102615 (Pubitemid 38506938)
3. P Collin-Osdoby 2004 Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin Circ Res 95 11 1046 1057 1:CAS:528:DC%2BD2cXpvVGmtb0%3D 10.1161/01.RES.0000149165.99974.12 15564564 (Pubitemid 39557891)
4. S Khosla 2001 Minireview: the OPG/RANKL/RANK system Endocrinology 142 12 5050 5055 1:CAS:528:DC%2BD3MXovVSntb8%3D 10.1210/en.142.12.5050 11713196 (Pubitemid 33131929)
5. A Levin GL Bakris M Molitch M Smulders J Tian LA Williams DL Andress 2007 Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 1 31 38 1:CAS:528:DC%2BD28XhtlSqtbnK 10.1038/sj.ki.5002009 17091124 (Pubitemid 44967731)
6. R Vanholder 2006 Chronic kidney disease in adults-UK guidelines for identification, management and referral Nephrol Dial Transplant 21 7 1776 1777 10.1093/ndt/gfl351 16798794 (Pubitemid 43985702)
7. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 1 31 41 1:STN:280:DyaE28%2FnsF2isw%3D%3D 10.1159/000180580 1244564
8. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 6 461 470 1:CAS:528:DyaK1MXitFChs7k%3D 10075613
9. EJ Hamilton V Rakic WA Davis SA Chubb N Kamber RL Prince TM Davis 2009 Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes Diabet Med 26 1 45 52 1:CAS:528:DC%2BD1MXjtVOqt7c%3D 10.1111/j.1464-5491.2008.02608.x 19125760
10. S Botolin LR McCabe 2006 Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways J Cell Biochem 99 2 411 424 1:CAS:528:DC%2BD28XhtVSktLzJ 10.1002/jcb.20842 16619259 (Pubitemid 44435559)
11. FR Brandao EJ Vicente CH Daltro M Sacramento A Moreira L Adan 2007 Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus Diabetes Res Clin Pract 78 3 334 339 1:CAS:528: DC%2BD2sXht12gur%2FM 10.1016/j.diabres.2007.04.009 17582646 (Pubitemid 350030314)
12. J Verhaeghe AM Suiker WJ Visser HE Van BR Van R Bouillon 1992 The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats J Endocrinol 134 3 485 492 1:CAS:528:DyaK38XlsVeqt7o%3D 10.1677/joe.0.1340485 1402554
13. M Schoppet KT Preissner LC Hofbauer 2002 RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function Arterioscler Thromb Vasc Biol 22 4 549 553 1:CAS:528:DC%2BD38XjtVOruro%3D 10.1161/01.ATV.0000012303.37971.DA 11950689 (Pubitemid 34408732)
14. LM Rasmussen L Tarnow TK Hansen HH Parving A Flyvbjerg 2006 Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients Eur J Endocrinol 154 1 75 81 1:CAS:528:DC%2BD28Xhs1aku78%3D 10.1530/eje.1.02049 16381994 (Pubitemid 43250739)
15. GD Xiang HL Sun LS Zhao 2007 Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients Diabetes Res Clin Pract 76 2 199 206 1:CAS:528:DC%2BD2sXjtFGhs7w%3D 10.1016/j.diabres.2006.09.008 17023086 (Pubitemid 46400128)
16. P Szulc LC Hofbauer AE Heufelder S Roth PD Delmas 2001 Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status J Clin Endocrinol Metab 86 7 3162 3165 1:CAS:528:DC%2BD3MXlt1Gjt78%3D 10.1210/jc.86.7.3162 11443182 (Pubitemid 32673481)
17. A Dovio ML Sartori A Angeli 2003 Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002 Clin Cancer Res 9 6 2384 2385 1:CAS:528:DC%2BD3sXksVajs7c%3D 12796409
18. DK Singh P Winocour K Farrington 2008 Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy Nat Clin Pract Nephrol 4 4 216 226 1:CAS:528:DC%2BD1cXjslSqtLg%3D 10.1038/ncpneph0757 18268525 (Pubitemid 351451302)
19. A Sjogren CH Floren A Nilsson 1986 Magnesium deficiency in IDDM related to level of glycosylated hemoglobin Diabetes 35 4 459 463 1:STN:280: DyaL287msFCjsQ%3D%3D 10.2337/diabetes.35.4.459 3956882
20. S Fatemi E Ryzen J Flores DB Endres RK Rude 1991 Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism J Clin Endocrinol Metab 73 5 1067 1072 1:CAS:528:DyaK38Xlt1SjtA%3D%3D 10.1210/jcem-73-5-1067 1939521
21. W Al-Badr KJ Martin 2008 Vitamin D and kidney disease Clin J Am Soc Nephrol 3 5 1555 1560 1:CAS:528:DC%2BD1cXhtFensrfJ 10.2215/CJN.01150308 18450926
22. M Schoppet N Al-Fakhri FE Franke N Katz PJ Barth B Maisch KT Preissner LC Hofbauer 2004 Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg's sclerosis and atherosclerosis J Clin Endocrinol Metab 89 8 4104 4112 1:CAS:528:DC%2BD2cXmslKlsrY%3D 10.1210/jc.2003-031432 15292354 (Pubitemid 39071519)
23. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy HQ Nguyen S Wooden L Bennett T Boone G Shimamoto M DeRose R Elliott A Colombero HL Tan G Trail J Sullivan E Davy N Bucay L Renshaw-Gegg TM Hughes D Hill W Pattison P Campbell S Sander G Van J Tarpley P Derby R Lee WJ Boyle 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 2 309 319 1:CAS:528:DyaK2sXislCgtLc%3D 10.1016/S0092-8674(00)80209-3 9108485
24. UM Malyankar M Scatena KL Suchland TJ Yun EA Clark CM Giachelli 2000 Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells J Biol Chem 275 28 20959 20962 1:CAS:528: DC%2BD3cXkvFGjt78%3D 10.1074/jbc.C000290200 10811631 (Pubitemid 30481782)